ThursdayAug 17, 2023 3:47 pm

QualityStocksNewsBreaks — Cepton Inc. (NASDAQ: CPTN) VP of Product Talks Record LiDAR Shipments, Q2 Earnings During Proactive Investors Interview

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, along with its Q2 performance and strategic developments are in the spotlight during a recent Proactive Investors interview. During the interview with Proactive’s Steve Darling, Cepton vice president of product Brunno Moretti provided an overview of the company’s second-quarter performance as well as key operational highlights. Moretti noted that Cepton has achieved a new company record for shipments of LiDAR technology across the automotive and smart infrastructure markets, which indicated the company's upward momentum; Moretti also explained that the company is projecting a significant increase in shipment volume…

Continue Reading

ThursdayAug 17, 2023 1:59 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Announces Q2, FH 2023 Results, Issues Corporate Update

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced operating results for the second quarter and first half of 2023. Among the highlights, the company reported that it was identified as a sample vendor in the “Data Discovery” category in the 2023 Data Security, Privacy, and Storage and Data Protection Technologies Gartner(R) Hype Cycle(TM) Reports, and that its Ransomware Recovery Manager was named “Best of Inexpensive Protection” and “Best for Kiosks” in “The Best Ransomware Protection for 2023.” “We continue to win new contracts and deepen our relationships with existing clients, including…

Continue Reading

ThursdayAug 17, 2023 1:35 pm

QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies

Renovaro BioSciences (NASDAQ: RENB), (formerly NASDAQ: ENOB), in March of 2023 announced that Dr. Anahid Jewett, a renowned cancer researcher in the field of immunotherapy for cancer, presented proof-of-concept data from two sets of humanized mouse studies conducted independently by her laboratory at the University of California, Los Angeles (“UCLA”). According to the announcement, the experiments demonstrated highly significant reductions in the weight and volume of pancreatic tumors following therapy with the company’s proprietary technology combining cell-, gene- and immunotherapy. The results correlated with strong immune responses, indicating proof-of-concept of the way the technology was intended to act. “I have…

Continue Reading

ThursdayAug 17, 2023 1:21 pm

QualityStocksNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Spotlighted in New Cantor Fitzgerald Research Brief

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, is featured in a recent Cantor Fitzgerald research brief. Noting that the stock “looks even more interesting post solid quarter and ahead of potential strategic acquisition,” the research brief reiterated its previous Overweight (“OW”) rating and 12-month price target of $6 for RVL Pharmaceutical shares, stating that RVLP’s commercial opportunities continue to be underappreciated and that upward earnings estimate revisions should drive the stock higher. The brief noted that…

Continue Reading

ThursdayAug 17, 2023 1:03 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces ‘Milestone’ Multimillion-Dollar Electronic Monitoring Contract

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, Internet of Things (“IoT”) and cybersecurity sectors, has secured a new contract to provide alcohol monitoring technologies and services in California. The contract, which is for an initial three-year term and is valued at up to $3 million, was secured through SPCB’s wholly owned subsidiary Leaders in Community Alternatives (“LCA”). Noting that the contract further solidifies the company's strong position in the electronic monitoring industry, SuperCom called the contract win another milestone for the company’s expansion into the U.S. market. According to the announcement, the contract is already…

Continue Reading

ThursdayAug 17, 2023 12:50 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Commencement of Stock Buyback Program

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the start of the company’s $25 million stock buyback program with the repurchase of 3.7 million shares of common stock for an aggregate of $3,626,000. The buyback program started on Aug. 16, 2023, and can continue through Dec. 31, 2023. Mullen’s chairman and CEO David Michery also purchased 102,040 shares in the open market on Aug. 16, 2023, at a price of $0.9842 per share. The company is committed to taking all available measures to regain compliance with the NASDAQ minimum $1.00 bid price requirement. “We believe that…

Continue Reading

WednesdayAug 16, 2023 2:50 pm

QualityStocksNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Confirms Crucial Structural Connection at Deer Horn

First Tellurium (CSE: FTEL) (OTC: FSTTF) today announced that an extensive mapping and sampling program at its Deer Horn property in west-central British Columbia has confirmed a crucial structural connection between the property’s Pond copper porphyry and gold-silver-tellurium systems. Under the direction of Dr. Lee Groat, consulting geologist and qualified person (“QP”) for First Tellurium, the mapping and sampling program is being conducted by a team of graduate students from the University of British Columbia and the University of St. Andrews. According to the update, preliminary results from the 2023 work confirm the primary structure within the Deer Horn property…

Continue Reading

WednesdayAug 16, 2023 2:41 pm

QualityStocksNewsBreaks – CISO Global Inc.’s (NASDAQ: CISO) Argo Edge Cloud Security Platform Tested at DEF Con with 125,000+ Cyberattacks

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, is reporting the successful testing of its Argo Edge security solution. According to the announcement, the newly launched AI-powered security solution was tested by thousands of hackers under real-world conditions at DEF Con, the premier cybersecurity and hacker convention held in Las Vegas this month. According to the announcement, DEF Con is attended by hackers from across the globe who compete and show off their skills through hacking competitions. The venue provides an opportunity for security vendors to take advantage of the collective cyberhacking talent and test…

Continue Reading

WednesdayAug 16, 2023 2:33 pm

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Mobilizes Drill Rigs, Advances Exploration Efforts at Ruby Graphite Project

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) today announced the mobilization of drill equipment for its Summer 2023 initial drill program at the Ruby Graphite project in Montana. Drill pad construction is underway for the program, which is planned to consist of 3,500 meters of core drilling at the project, located in Beaverhead County, Montana, U.S.A. “The mobilization of drill rigs marks an important milestone for Reflex as we advance our exploration efforts at the Ruby Graphite project,” said Paul Gorman, CEO of Reflex Advanced Materials. “We are confident that this drill program will not only confirm the presence of…

Continue Reading

WednesdayAug 16, 2023 2:25 pm

QualityStocksNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Enters into Agreements for $5M Registered Direct Offering

RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, has entered into definitive agreements. The offering is expected to close on or about Aug. 18, 2023, and will be subject to customary closing conditions. The company anticipates gross proceeds from the registered direct offering to total approximately $5 million; RVL Pharmaceuticals plans to use the funds for general corporate purposes. The registered direct offering agreements are for the purchase and sale of 11,870,846 of RVLP ordinary shares (or ordinary…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered